Loading...
 
Mediterr J Rheumatol 2018;29(3):173-7
Extensive phenotyping of vascular damage in non-infectious primary vasculitides with the use of non-invasive vascular biomarkers: prevalence, pathogenesis and response to treatment
Authors Information

Department of Pathophysiology, “Laiko” Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece

References
  1. Elefante E, Tripoli A, Ferro F, Baldini C: One year in review: systemic vasculitis. Clin Exp Rheumatol 2016;34(Suppl.97):S1-S6. [PMID: 27214397]
  2. Nelson S S, Pande S, Kushwah A P S. A study of atherosclerosis in Systemic vasculitis. Int J Sci Stud 2014;2:25-9.
  3. Eleftheriadis E, Eleftheriadis N. Coronary Artery Disease and Systemic Vasculitis: Case report and Review. Coronary Artery Diseases, edited by Dr IIIya Chaikovsky. INTECH 2012;13:281-300. [http://doi.org/10.5772/30544]
  4. Adebajo A, Dickson D J. Collected reports on the Rheumatic Diseases 2005 series 4 (revised) Primary Systemic Vasculitis. Arthritis Research Campaign (arc) 2005;70-1.
  5. Savage C O, Harper L, Adu D. Primary systemic vasculitis. Lancet 1997;349:553-8. [PMID: 9048802]
  6. Kernani T, Warrington K, Amin S. Malignancy risk in vasculitis. Ther Adv Musculoskel Dis 2011;3(1):55-63. [https://doi.org/10.1177/1759720X10387460] [PMID: 22870466]
  7. Hong J, Marson D, Shirai T, Weyand C. Accelerated atherosclerosis in patients with chronic inflammatory rheumatologic conditions. Int J Clin Rheumatol 2015;10(5):365-81. [PMID: 27042216]
  8. Shirwany N A, Zou M-H. Arterial stiffness: a brief review. Acta Pharmacol Sin 2010;31:1267-76. [http://doi.org/10.1038/aps.2010.123] [PMID: 20802505]
  9. Argyropoulou O D, Protogerou A D, Sfikakis P P. Accelerated atheromatosis and arteriosclerosis in primary systemic vasculitides: current evidence and future perspectives. Curr Opin Rheumatol 2018;30(1):36-43. [https://doi.org/10.1097/BOR.0000000000000453] [PMID: 29040156]